Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The predictive capacity of personal genome sequencing.

Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE.

Sci Transl Med. 2012 May 9;4(133):133ra58. doi: 10.1126/scitranslmed.3003380. Epub 2012 Apr 2.

2.

Genomic sequencing in cancer.

Tuna M, Amos CI.

Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23. Review.

3.

Direct-to-consumer personal genome testing and cancer risk prediction.

Bellcross CA, Page PZ, Meaney-Delman D.

Cancer J. 2012 Jul-Aug;18(4):293-302. doi: 10.1097/PPO.0b013e3182610e38. Review.

PMID:
22846729
4.

Genomic medicine and risk prediction across the disease spectrum.

Kotze MJ, L├╝ckhoff HK, Peeters AV, Baatjes K, Schoeman M, van der Merwe L, Grant KA, Fisher LR, van der Merwe N, Pretorius J, van Velden DP, Myburgh EJ, Pienaar FM, van Rensburg SJ, Yako YY, September AV, Moremi KE, Cronje FJ, Tiffin N, Bouwens CS, Bezuidenhout J, Apffelstaedt JP, Hough FS, Erasmus RT, Schneider JW.

Crit Rev Clin Lab Sci. 2015;52(3):120-37. doi: 10.3109/10408363.2014.997930. Epub 2015 Jan 19. Review.

PMID:
25597499
5.

Whole-Genome Sequencing in Healthy People.

Lindor NM, Thibodeau SN, Burke W.

Mayo Clin Proc. 2017 Jan;92(1):159-172. doi: 10.1016/j.mayocp.2016.10.019. Review.

6.

Increasing precision in medicine - tackling the bottleneck of variant interpretation.

Baker M.

Drugs Today (Barc). 2016 Jul;52(7):395-8. doi: 10.1358/dot.2016.52.7.2533694. Review.

PMID:
27540598
7.

The personal genome and the practice of cardiovascular medicine.

Marian AJ.

Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan;6(4):13-20. Review.

PMID:
21088654
8.

Analyzing the cancer methylome through targeted bisulfite sequencing.

Lee EJ, Luo J, Wilson JM, Shi H.

Cancer Lett. 2013 Nov 1;340(2):171-8. doi: 10.1016/j.canlet.2012.10.040. Epub 2012 Nov 28. Review.

9.

Sequencing your genome: what does it mean?

Marian AJ.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):3-6. Review.

10.

High-throughput sequencing technologies.

Reuter JA, Spacek DV, Snyder MP.

Mol Cell. 2015 May 21;58(4):586-97. doi: 10.1016/j.molcel.2015.05.004. Review.

11.

Next-generation sequencing and empowering personalised cancer medicine.

McDermott U.

Drug Discov Today. 2015 Dec;20(12):1470-5. doi: 10.1016/j.drudis.2015.10.008. Epub 2015 Oct 19. Review.

PMID:
26494142
12.

Personalized medicine: hope or hype?

Salari K, Watkins H, Ashley EA.

Eur Heart J. 2012 Jul;33(13):1564-70. doi: 10.1093/eurheartj/ehs112. Epub 2012 Jun 1. Review.

13.

Rare-disease genetics in the era of next-generation sequencing: discovery to translation.

Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE.

Nat Rev Genet. 2013 Oct;14(10):681-91. doi: 10.1038/nrg3555. Epub 2013 Sep 3. Review.

PMID:
23999272
14.

Next-generation sequencing technologies: breaking the sound barrier of human genetics.

Bahassi el M, Stambrook PJ.

Mutagenesis. 2014 Sep;29(5):303-10. doi: 10.1093/mutage/geu031. Review.

PMID:
25150023
15.

Disease-targeted sequencing: a cornerstone in the clinic.

Rehm HL.

Nat Rev Genet. 2013 Apr;14(4):295-300. doi: 10.1038/nrg3463. Epub 2013 Mar 12. Review.

16.

Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.

Lin X, Tang W, Ahmad S, Lu J, Colby CC, Zhu J, Yu Q.

Hear Res. 2012 Jun;288(1-2):67-76. doi: 10.1016/j.heares.2012.01.004. Epub 2012 Jan 14. Review.

Supplemental Content

Support Center